NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets
released its latest key findings for all current investors, traders, and shareholders of Entergy Corporation (NYSE:ETR), Schneider
National, Inc. (NYSE:SNDR), C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), PTC Therapeutics, Inc. (NASDAQ:PTCT), Guess?, Inc.
(NYSE:GES), and Immunomedics, Inc. (NASDAQ:IMMU), including updated fundamental summaries, consolidated fiscal reporting, and
fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ETR DOWNLOAD: http://Fundamental-Markets.com/register/?so=ETR
SNDR DOWNLOAD: http://Fundamental-Markets.com/register/?so=SNDR
CHRW DOWNLOAD: http://Fundamental-Markets.com/register/?so=CHRW
PTCT DOWNLOAD: http://Fundamental-Markets.com/register/?so=PTCT
GES DOWNLOAD: http://Fundamental-Markets.com/register/?so=GES
IMMU DOWNLOAD: http://Fundamental-Markets.com/register/?so=IMMU
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Entergy Corporation
(NYSE:ETR), Schneider National, Inc. (NYSE:SNDR), C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), PTC Therapeutics, Inc.
(NASDAQ:PTCT), Guess?, Inc. (NYSE:GES), and Immunomedics, Inc. (NASDAQ:IMMU) on a fundamental level and outlines the overall demand
for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall
direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you
are reading all relevant material information. All information in this release was accessed May 7th, 2018. Percentage calculations
are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ENTERGY CORPORATION (ETR) REPORT OVERVIEW
Entergy's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Entergy reported revenue of $2,723.88MM vs $2,588.46MM (up
5.23%) and basic earnings per share $0.73 vs $0.46 (up 58.70%). For the twelve months ended December 31st, 2017 vs December 31st,
2016, Entergy reported revenue of $11,074.48MM vs $10,845.64MM (up 2.11%) and basic earnings per share $2.29 vs -$3.26. Entergy is
expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS
for the same quarter last year was $3.11. The estimated EPS forecast for the next fiscal year is $5.81 and is expected to report on
February 22nd, 2019.
To read the full Entergy Corporation (ETR) report, download it here: http://Fundamental-Markets.com/register/?so=ETR
-----------------------------------------
SCHNEIDER NATIONAL, INC. (SNDR) REPORT OVERVIEW
Schneider National's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Schneider National reported revenue of $1,139.00MM vs
$1,006.40MM (up 13.18%) and basic earnings per share $0.27 vs $0.14 (up 92.86%). For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Schneider National reported revenue of $4,383.60MM vs $4,045.70MM (up 8.35%) and basic earnings per share
$2.28 vs $1.00 (up 128.00%). Schneider National is expected to report earnings on August 7th, 2018. The report will be for the
fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.23. The estimated EPS forecast for the
next fiscal year is $1.66 and is expected to report on February 7th, 2019.
To read the full Schneider National, Inc. (SNDR) report, download it here: http://Fundamental-Markets.com/register/?so=SNDR
-----------------------------------------
C.H. ROBINSON WORLDWIDE, INC. (CHRW) REPORT OVERVIEW
C.H. Robinson Worldwide's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, C.H. Robinson Worldwide reported revenue of $3,959.79MM
vs $3,414.98MM (up 15.95%) and basic earnings per share $1.09 vs $0.87 (up 25.29%). For the twelve months ended December 31st, 2017
vs December 31st, 2016, C.H. Robinson Worldwide reported revenue of $14,869.38MM vs $13,144.41MM (up 13.12%) and basic earnings per
share $3.59 vs $3.60 (down 0.28%). C.H. Robinson Worldwide is expected to report earnings on July 18th, 2018. The report will be
for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.78. The estimated EPS forecast
for the next fiscal year is $4.82 and is expected to report on January 29th, 2019.
To read the full C.H. Robinson Worldwide, Inc. (CHRW) report, download it here: http://Fundamental-Markets.com/register/?so=CHRW
-----------------------------------------
PTC THERAPEUTICS, INC. (PTCT) REPORT OVERVIEW
PTC Therapeutics' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, PTC Therapeutics reported revenue of $78.03MM vs $25.19MM
(up 209.75%) and basic earnings per share $0.09 vs -$0.78. For the twelve months ended December 31st, 2017 vs December 31st, 2016,
PTC Therapeutics reported revenue of $194.39MM vs $82.71MM (up 135.04%) and basic earnings per share -$2.02 vs -$4.17.
To read the full PTC Therapeutics, Inc. (PTCT) report, download it here: http://Fundamental-Markets.com/register/?so=PTCT
-----------------------------------------
GUESS?, INC. (GES) REPORT OVERVIEW
Guess?'s Recent Financial Performance
For the three months ended January 31st, 2018 vs January 31st, 2017, Guess? reported revenue of $777.34MM vs $660.36MM (up
17.72%) and basic earnings per share $0.01 vs $0.08 (down 87.50%). Guess? is expected to report earnings on May 23rd, 2018. The
report will be for the fiscal period ending April 30th, 2018. The reported EPS for the same quarter last year was -$0.24. The
estimated EPS forecast for the next fiscal year is $1.23 and is expected to report on March 20th, 2019.
To read the full Guess?, Inc. (GES) report, download it here: http://Fundamental-Markets.com/register/?so=GES
-----------------------------------------
IMMUNOMEDICS, INC. (IMMU) REPORT OVERVIEW
Immunomedics' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Immunomedics reported revenue of $0.60MM vs $0.38MM (up
55.47%) and basic earnings per share -$0.02 vs -$0.23. For the twelve months ended June 30th, 2017 vs June 30th, 2016, Immunomedics
reported revenue of $3.09MM vs $3.23MM (down 4.39%) and basic earnings per share -$1.47 vs -$0.62. Immunomedics is expected to
report earnings on May 9th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same
quarter last year was -$0.22.
To read the full Immunomedics, Inc. (IMMU) report, download it here: http://Fundamental-Markets.com/register/?so=IMMU
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for
over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide.
Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation
holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered
Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA®
charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed
status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including
policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release
should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at
compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets,
Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the
opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material
provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication
of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment
adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer,
disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For
republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are
registered trademarks owned by Financial Industry Regulatory Authority, Inc.
